Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors

Journal of Medicinal Chemistry

Volumn 42, Issue 7, 1999, Pages 1282-1292

  Zhuo, Jin Cong ^a   Cai, Jianping ^a   Soloway, Albert H ^a   Barth, Rolf F ^a   Adams, Dianne M ^a   Ji, Weihua ^a   Tjarks, Werner ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORON; ETHIDIUM; HYDROXYL GROUP; N5 [[4 (DIHYDROXYBORYL)PHENYL]METHYL]SPERMIDINE; POLYAMINE; SPERMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CELL GROWTH; GLIOMA; IMPLANT; NEUTRON CAPTURE THERAPY; NONHUMAN; RAT; SYNTHESIS;

ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CATTLE; DNA; GLIOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; RATS; SPERMIDINE; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033535562     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980703f     Document Type: Article

References (75)

1. Locher, G. L. Biological effects and therapeutic possibilities of neutrons. Am. J. Roentgenol. Ther. 1936, 36, 1.
2. Hawthorne, M. F. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew. Chem., Int. Ed. Engl. 1993, 32, 950-84.
3. Morin, C. The chemistry of boron analogues of biomolecules. Tetrahedron 1994, 50, 12521-12569.
4. Soloway, A. H.; Tjarks, W.; Barnum, B. A.; Rong, F.-G.; Barth, R. F.; Codogni, I. M.; Wilson, J. G. The chemistry of neutron capture therapy. Chem. Rev. 1998, 98, 1515-1562.
5. Barth, R. F.; Soloway, A. H.; Goodman, J. H.; Gahbauer, R. E.; Gupta, N.; Blue, T. B.; Yang, W.; Tjarks, W. Boron neutron capture therapy of brain tumor: An emerging therapeutic modality. Neurosurgery 1999, 44, 433-451.
6. Kabalka, G. W. Recent developments in boron neutron capture therapy. Exp. Opin. Ther. Patents 1998, 8, 545-551.
7. 10B neutron capture therapy: Enhancement of tumor dose via beam filtration and dose rate, and the effect of these parameters on minimum boron content: A theoretical evaluation. Int. J. Radiat. Oncol., Biol., Phys. 1986, 11, 831-840.
8. Zamenhof, R.G.; Kalend, A.M.; Bloomer, W. D. BNCT: Looking for a few good molecules. J. Natl. Cancer Inst. 1992 ,84, 1290-1291.
9. Nakamura, H.; Fujiwara, M.; Yamamoto, Y. A concise synthesis of enantiomerically pure L-(4-boronophenyl)alanine from L-tyrosine. J. Org. Chem. 1998, 60, 7529-7530.
10. Malan, C.; Morin, C. A concise preparation of 4-borono-L-phenylalanine (L-BPA) from L-phenylalanine. J. Org. Chem. 1998, 63, 8019-8020.
11. Radel, P. A.; Kahl, S. B. Enantioselective synthesis of L-and D-carboranylalanine. J. Org. Chem. 1996, 61, 4582-4588.
12. Takagaki, M.; Ono, J.; Oda, Y.; Kikuchi, H.; Nemoto, H.; Iwamoto, S.; Cai, J.; Yamamoto, Y. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors. Cancer Res. 1996, 56, 2017-2020.
13. Wyzlic, I. M.; Tjarks, W.; Soloway, A. H.; Perkins, D. J.; Burgos, M.; O'Reilly, K. P. Synthesis of carboranyl amino acids, hydantoins, and barbiturates. Inorg. Chem. 1996, 35, 4541-4547.
14. Karnbrock, W.; Musiol, H. J.; Moroder, L. Enantioselective synthesis of S-o-carboranylalanine via methylated bislactim ethers of 2,5-diketopiperazines. Tetrahedron 1996, 51, 1187-1196.
15. Nemoto, H.; Cai, J.; Asao, N.; Iwamoto, S.; Yamamoto, Y. Synthesis and biological properties of water-soluble p-boronophenylalanine dervatives. Relationship between water solubility, cytotoxicity, and celluler uptake. J. Med. Chem. 1995, 38, 1673-1678.
16. Leush, A.; Jungblut, L.; Moroder, L. Design and synthesis of carboranyl peptides as carriers of 1,2-dicarbadodecarborane clusters. Synthesis 1994, 305-308.
17. Kane, R. R.; Pak, R. H.; Hawthorne, M. F. Solution-phase segment synthesis of boron-rich peptides. J. Org. Chem. 1993, 58, 991-992.
18. Kane, R. R.; Hawthorne, M. F. Novel carboranyl amino acids and peptides: reagent for antibody modification and subsequent neutron-capture studies. Bioconjugate Chem. 1991, 2, 242-253.
19. Schwyzer, R.; Do, K. Q.; Eberle, A. N.; Fauchère, J. L. Synthesis and biological properties of enkephalin-like peptides containing carboranylalanine in place of phenylalanine. Helv. Chim. Acta 1981, 84, 2078-2083.
20. Soloway, A. H.; Zhuo, J.-C.; Rong, F.-G.; Lunato, A. J.; Ives, D. H.; Barth, R. F.; Anisuzzaman, A. K. M.; Barth, C. D.; Barnum, B. A. Identification, development, synthesis and evaluation of boron-containing nucleosides for neutron capture therapy. J. Organomet. Chem., in press.
21. Lesnikowski, Z. J.; Schinazi, R. F. Boron neutron capture therapy of cancers: Nucleic bases, nucleosides, and oligonucleotides as potential boron carriers. Pol. J. Chem. 1995, 69, 827-840.
22. Goudgaon, N. M.; El-Kattan, G. F.; Schinazi, R. F. Boron containing pyrimidines, nucleosides, and oligonucleotides for neuton capture therapy. Nucleosides Nucleotides 1994, 13, 849-880.
23. Wang, J.; Lunato, A. J.; Anisuzzaman, A. K. M.; Ikeda, S.; Ji, W.; Rong, F.-G.; Eriksson, S.; Ives, D. H.; Soloway, A. H.; Tjarks, W. Evaluation of carboranyl 2′-deoxyuridine derivatives as substrates for human thymidine kinases 1 and 2. In Frontiers Neutron Capture Therapy; Hawthorne, M. F., Wiersema, R. J., Eds.; Plenum Press: New York, 1999, in press.
24. Graciet, J.-C. G.; Shi, J.; Schinazi, R. Synthesis and biological properties of the four optical isomers of 5-o-carboranyl-2′,3′-didehydro-2′,3′-dideoxyuridine. Nucleosides Nucleotides 1998, 17, 711-727.
25. Rong, F.-G.; Soloway, A. H.; Ikeda, S.; Ives, D. H. Synthesis and biochemical activity of hydrophilic carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation and BNCT. Nucleosides Nucleotides 1997, 16, 379-401.
26. Yamamoto, Y.; Imamura, K.-I. Synthesis and in vitro evaluation of sugar-modified carboranyluridines. Bioorg. Med. Chem. Lett. 1996, 6, 1855-1858.
27. Rong, F. G.; Soloway, A. H.; Ikeda, S.; Ives, D. Synthesis and biochemical activity of 5-tethered carborane-containing pyrimidine nuceosides as potential agents for DNA incorporation. Nucleosides Nucleotides 1995, 14, 1873-1887.
28. Chen, Y. Q.; Qu, F. C.; Zhang, Y. B. Diuridine 3′,5′-boranophosphate: Preparation and properties. Tetrahedron Lett. 1995, 36, 745-748.
29. Rattan, G. F.-El; Goudgaon, N. M.; Ilksoy, N.; Huang, J.-T.; Watanabe, K. A.; Sommadossi, J.-P.; Schinazi, R. Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)uracil. J. Med. Chem. 1994, 37, 2583-2588.
30. Rong, F. G.; Soloway, A. H.; Ikeda, S.; Ives, D. H. Synthesis of 5-tethered carborane-containing pyrimidine nucleosides as potential agents for DNA incorporation. Nucleosides Nucleotides 1994, 13, 2021-2034.
31. Miura, M.; Micca, P. L.; Fisher, C. D.; Gordon, C. R.; Heinrichs, J. C.; Slatkin, D. N. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy. Br. J. Radiol. 1998, 71, 773-781.
32. Phadke, A. S.; Morgan, A. R. Synthesis of carboranyl porphyrins: Potential drugs for boron neutron capture therapy. Tetrahedron Lett. 1993, 34, 1725-1728.
33. Miura, M.; Gabel, D.; Oenbrink, G.; Fairchild, R. G. Preparation of carboranyl porphyrins for boron neutron capture therapy. Tetrahedron Lett. 1990, 31, 2247-2250.
34. Kahl, S. B.; Koo, M.-S. Synthesis of tetrakis-carborane-carboxylate esters of 2,4-bis-(α,β-dihydroxyehtyl)-deuterioporphyrin IX. J. Chem. Soc., Chem. Commun. 1990, 1769-1771.
35. Yamamoto, Y.; Cai, J.; Nakamura, H.; Sadayori, N.; Asao, N.; Nemoto, H. Synthesis of netropsin and distamycin analogues bearing o-carborane and their DNA recognition. J. Org. Chem. 1995, 60, 3352-3357.
36. Cai, J.; Soloway, A. H. Synthesis of carboranyl polyamines for DNA targeting. Tetrahedron Lett. 1996, 9283-9286.
37. Kelly, D. P.; Bateman, S. A.; Hook, H. J.; Martin, R. F.; Reum, M. E.; Rose, M.; Whittaker, A. R. D. DNA Binding compounds. VI Synthesis and characterization of 2,5′-disubstituted bibenzimidazoles related to the DNA minor groove binder hoechst 33258. Aust. J. Chem. 1994, 47, 1751-1769.
38. Kelly, D. P.; Bateman, S. A.; Martin, R. F.; Reum, M. E.; Rose, M.; Whittaker, A. R. D. DNA Binding compounds. V. Synthesis and characterization of boron-containing bibenzimidazoles related to the DNA minor groove binder hoechst 33258. Aust. J. Chem. 1994, 47, 247-262.
39. Pegg, A. E.; McCann, P. P. Polyamine metabolism and function. Am. J. Physiol. (Cell Physiol. 12) 1982, C212-C221.
40. Tabor, C. W.; Tabor, H. Polyamine. Annu. Rev. Biochem. 1984, 53, 749-790.
41. Jaune, J.; Poso, H. R. Polyamines in rapid growth and cancer. Biochim. Biophys. Acta 1978, 473, 241-293.
42. Moulinoux, J. P.; Darcel, P.; Quemener, V.; Havouis, R.; Seiler, N. Inhibition of the growth of U-251 human glioblastoma in nude mice by polyamine deprivation. Anticancer Res. 1991, 11, 175-180.
43. Regate, E. S.; Boggs, S.; Grudziak, A.; Deutsch, M. Polyamines in brain tumor therapy. J. Neuro-Oncol. 1995, 25, 167-179.
44. Marton, L. J.; Pegg, A. E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 55-91.
45. Bergeron, R. J. Method for the selective modification of spermidine and its homologues. Acc. Chem. Res. 1986, 19, 105-113.
46. Bachrach, U. Polyamines and nucleic acids. Function of Naturally Occurring Polyamines; Academic Press: New York, 1973; pp 63-73.
47. Wemmer, D. E.; Scrivenugopal, K. S.; Reid, B. R.; Morris, D. R. Nuclear magnetic resonance studies of polyamine binding to a defined DNA sequence. J. Mol. Biol. 1985, 185, 457.
48. Besley, S.; Cullis, P. M.; Partridge, R.; Symons, M. C. R.; Wheelhouse, R. T. Motion of polyammonium ions on aqueous solution of DNA. Chem. Phys. Lett. 1990, 765, 120.
49. Cohen, G. M.; Cullis, P. M.; Hartley, J. A.; Mather, A.; Symons, M. C. R.; Wheelhouse, R. T. Targeting of cytotoxic agents by polyamines: Synthesis of a chlorambucil-spermidine conjugate. J. Chem. Soc., Chem. Commun. 1992, 298.
50. Holley, J. L.; Mather, A.; Wheelhouse, R. T.; Cullis, P. M.; Hartley, J. A.; Bingham, J. P.; Cohen, G. M. Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res. 1992, 52, 4190-4195.
51. Li, Y.; Eisenman, J. L.; Sentz, D. L.; Rogers, F. A.; Pan, S. S.; Hu, L. T.; Egorin, M. L.; Callery, P. S. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogues, 1,12-diaziridinyl-2,9-diazadodecane. J. Med. Chem. 1996, 39, 339-341.
52. Stark, P. A.; Thrall, B. D.; Meadows, G. G.; Abdel-Monem, M. M. Synthesis and evaluation of novel spermidine derivatives as targeted cancer chemotherapeutic agents. J. Med. Chem. 1992, 35, 4264-4269.
53. Seiler, N.; Delcros, J. G.; Moulinoux, J. P. Polyamine transport in mammalian cells. An update. Int. J. Biochem. Cell Biol. 1996, 28, 843-861.
54. Cai, J.; Soloway, A. H.; Barth, R. F.; Adams, D. M.; Hariharan, J. R.; Wyzlic, I. M.; Radcliffe, K. Boron-containg polyamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation. J. Med. Chem. 1997, 40, 3887-3896.
55. Hariharan, J. R.; Wyzlic, I. M.; Soloway, A. H. Synthesis of novel boron-containing polyamines-agents for DNA targeting in neutron capture therapy. Polyhedron 1995, 14, 823-825.
56. Hariharan, J. R. Design and synthesis of novel polyamine derivatives for boron neutron capture therapy for cancer. Dissertation, The Ohio State University, 1995.
57. Scobie, M.; Mahon, M. P.; Threadgrill, M. D. Tumor-targetted boranes: Coupling of close-carboranes to substituted 2-nitroimidazoles via 1,3-dipolarcycloaddition. J. Chem. Soc., Perkin Trans. 1 1994, 203-210.
58. Snyder, H. R.; Reedy, A. J.; Lennarz, Wm. J. Synthesis of aromatic boronic acid. Aldehydo boronic acids and a boronic acid analogue of tyrosine. J. Am. Chem. Soc. 1958, 80, 835-838.
59. Liu, L.; Barth, R. F.; Tjarks, W.; Soloway, A. H.; Anisuzzaman, A. K. M In vitro and in vivo evaluation of carboranyl uridine as boron delivery agents for neutron caputre therapy. Anticancer Res. 1996, 16, 113.
60. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
61. Edwards, M. L.; Snyder, R. D.; Stemerick, D. M. Synthesis and DNA-binding properties of polyamine analogues. J. Med. Chem. 1991, 34, 2414-2420.
62. Stewart, K. D. The effect of structural changes in a polyamine backbone on its DNA-binding properties. Biochem. Biophys. Res. Commun. 1988, 152, 1441-1446.
63. Cain, B. F.; Baguley, B. C.; Denny, W. A. Potential antitumor agents 28. deoxyribonucleic acid polyintercalating agents. J. Med. Chem. 1978, 21, 658-668.
64. Barth, R. F.; Adams, D. M.; Soloway, A. H.; Mechetner, E. B.; Alam, F.; Anisuzzaman, A. K. M. Determination of boron in tissues and cells using direct current plasma atomic emission spectroscopy. Anal. Chem. 1991, 63, 890-893.
65. Zakharkin, L. I.; Kalinin, V. N. On the reaction of amines with barenes. Tetrahedron Lett. 1965, 407-409.
66. Hawthorne, M. F. Biochemical applications of boron cluster chemistry. Pure Appl. Chem. 1991, 63, 327-334.
67. Grafstein, D.; Bobinski, J.; Dvorak, J.; Smith, H.; Schwartz, N.; Cohen, M. S.; Fein, M. M. Carboranes. III. Reactions of the carboranes. Inorg. Chem. 1963, 2, 1120-1124.
68. Hawthorne, M.; Wegner, P. A.; Stafford, R. C. Comments on the raction of amines with 1,2-dicabaclovododecaborane(12). Inorg. Chem. 1963, 2, 1126.
69. Burgstahler, A. W.; Weigel, L. O.; Sanders, M. E.; Shaefer, C. G.; Bell, W. J.; Vuturo, S. B. Synthesis and activity of 29-hydroxy-3,11-dimethyl-2-nonacosanone, component B of the German cockroach sex pheromone. J. Org. Chem. 1977, 42, 566-568.
70. Ko, L.; Koestner, A.; Wechslen, W. Morphological characterization of nitrosurea-induced glioma cell line and clones. Acta Neuropathol. (Berlin) 1980, 51, 23-31.
71. Ko, L.; Koestner, A.; Wechslen, W. Characterization of cell cycle and biological parameters of transplantable glioma cell lines and cells. Acta Neuropathol. (Berlin) 1980, 51, 107-111.
72. Yong, J. H.; Barth, R. F.; Rotaru, J. H.; Wyzlic, I. M.; Soloway, A. H. Evaluation of in vitro cytotoxicity of carboranyl amino acids, their chemical precursors and nido carboranyl amino acids for boron neutron capture therapy, Anticancer Res. 1996, 15, 2039-2044.
73. Barth, R. F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neuro-Oncol. 1998, 36, 91-102.
74. Vertosick, F. T., Jr.; Selker, R. G.; Raudall, M. S.; Kristofik, M. P.; Rehn, T. A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro. J. Neuro-Oncol. 1994, 19, 97-103.
75. Bergeron, R. J.; Neims, A. H.; McManis, J. S.; Hawthorne, T. R.; Vinson, J. R. T.; Bortell, R.; Ingeno, M. J. Synthetic polyamine analogues as antineoplastics. J. Med. Chem. 1988, 31, 1183-1190.